NASDAQ$THRM

Gentherm Incorporated · Q2 2022 earnings

Q2 2022 earnings · · Investor relations

Briefing

Gentherm's Q2 2022 financial performance was impacted by a challenging operating environment, but the company secured new business and made strategic acquisitions.

Gentherm's Q2 2022 product revenues decreased by 2.0% year-over-year to $260.7 million. Despite the challenging environment, the company secured $600 million in new automotive business and acquired Jiangmen Dacheng Medical Equipment Co. Ltd. The company updates its full-year 2022 guidance to include the completed acquisitions.

  • Product revenues decreased by 2.0% year-over-year to $260.7 million.
  • GAAP diluted earnings per share was $0.21, compared to $0.74 for the prior-year period.
  • Adjusted diluted earnings per share was $0.25, compared to $0.85 in the prior-year period.
  • Secured new automotive business awards totaling $600 million in the quarter.

Headline financials

Total Revenue

$261M

Previous: $266M-2.0%
EPS (adj)

$0.25

Previous: $0.85-70.6%
Adjusted EBITDA

$21.4M

Previous: $43.7M-51.0%
Capital Expenditures

-$15.4M

Previous: -$20.7M+25.3%
Free Cash Flow

-$8.38M

Previous: $4.12M-303.2%
Net Income

$7.07M

Previous: $24.8M-71.5%
Operating Income

$7.74M

Previous: $31.7M-75.6%
Gross Profit

$59.4M

Previous: $79.2M-25.0%
Cash & Equivalents

$157M

Previous: $187M-15.8%
Total Assets

$947M

Previous: $934M+1.4%
Stock-Based Comp

$2.98M

Previous: $1.74M+71.6%

Revenue & EPS history

Gentherm · Revenue · Quarterly

$261M

Q2 2022-2%vs Q2 2021
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Revenue by segment

Gentherm · $479M total across 5 segments · Q3 2022

  • Automotive segment
    $323M
  • Climate Control Seats
    $112M
  • Lumbar and Massage Comfort Solutions
    $22.7M
  • Other Automotive
    $11.4M
  • Medical segment
    $10.4M

Forward guidance

The company updates its full-year 2022 guidance that was initially provided on its year-end 2021 earnings release on February 17, 2022, based on year-to-date performance and to include the completed acquisition of Alfmeier as of August 1, 2022 and the completed acquisition of Dacheng Medical as of July 13, 2022

Tailwinds

  • Product revenues between $1.15 billion and $1.25 billion, based on the current forecast of customer orders, supply chain constraints, estimated recovery of industry-wide semiconductor supply, light vehicle production in the Company’s key markets growing at a low single-digit rate in 2022 versus 2021 and current foreign exchange rates
  • Adjusted EBITDA between 10% and 12% of product revenues
  • Assumes approximately $100 million of product revenues and high single-digit EBITDA margin rate from the acquisitions
  • Full-year effective tax rate between 29% and 31%
  • Capital expenditures between $50 million and $60 million

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2022

Historical avgQ2 2022

+0.7%

Avg return

Earnings day

+0.5%

Avg return

5 days after

+0.4%

Avg return

30 days after

56%

37 / 66 earnings

Positive

+18.4%

Q4 2023

Best reaction

-22.7%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+9.3%+4.0%+13.7%
Q4 2025+1.4%+10.8%-10.9%
Q3 2025+8.2%+7.2%+1.9%
Q2 2025-1.7%-1.9%-3.4%
Q1 2025-0.3%+3.8%+8.2%
Q4 2024-7.7%-6.0%-16.8%
Q3 2024+1.0%+5.8%+1.4%
Q2 2024+7.5%-1.0%+0.5%
Q1 2024+3.1%+1.7%+5.3%
Q4 2023+18.4%+12.8%+11.5%
Q3 2023-22.7%-23.7%-11.7%
Q2 2023+7.7%+8.3%+0.7%
Q1 2023+5.1%+4.5%+0.7%
Q4 2022-7.2%-9.1%-17.7%
Q3 2022+1.5%+13.6%+25.0%
Q2 2022-5.9%-5.1%-7.7%
Q1 2022-1.1%-6.1%+1.9%
Q4 2021-1.0%-2.0%-17.1%
Q3 2021-16.8%-8.6%-5.2%
Q2 2021+15.0%+15.5%+22.0%
Q1 2021-6.4%-6.0%-4.6%
Q4 2020+2.3%+2.7%+9.6%
Q3 2020+4.3%+10.9%+28.3%
Q2 2020+5.7%+5.7%+11.9%
Q1 2020+4.7%+2.3%+19.3%
Q4 2019+5.1%+0.2%-38.7%
Q3 2019-4.2%-6.3%-5.7%
Q2 2019+1.0%+0.5%-12.3%
Q1 2019-0.2%-0.0%-6.0%
Q4 2018-0.2%-0.2%-14.6%
Q3 2018+13.3%+17.7%+18.5%
Q2 2018+6.8%+9.8%+18.8%
Q1 2018-3.1%-2.7%+0.6%
Q4 2017+4.1%-0.3%+6.8%
Q3 2017-6.1%-4.8%+0.3%
Q2 2017-11.3%-15.2%-23.0%
Q1 2017+2.3%+2.2%+4.0%
Q4 2016+6.6%+2.4%+3.5%
Q3 2016-3.8%-5.5%+9.1%
Q2 2016-11.7%-16.8%-14.1%
Q1 2016-15.5%
Q4 2015-0.4%
Q3 2015+7.0%
Q2 2015-0.2%
Q1 2015+2.2%
Q4 2014+5.8%
Q3 2014-5.3%
Q2 2014+2.8%
Q1 2014+6.6%
Q4 2013+14.2%
Q3 2013+14.3%
Q2 2013-7.9%
Q1 2013+8.0%
Q1 2011+2.2%
Q4 2012+1.6%
Q3 2012+6.5%
Q2 2012+10.3%
Q1 2012+1.2%
Q4 2011-4.1%
Q3 2010+0.9%
Q3 2011+0.9%
Q2 2011-6.6%
Q2 2010-6.6%
Q4 2009-6.6%
Q4 2010-6.6%
Q1 2010-3.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro